Researchers collaborate to seek FDA approval for drug treatment for rare disease
Author: Gene Stowe and Marissa Gebhard
University of Notre Dame alumnus Norbert Wiech founded Lysomics LLC to manage the clinical development needed to bring to market a promising new treatment for people with Niemann-Pick Type C (NPC) disease. FDA support is being sought for early clinical exploration of an approved drug to fight this rare disease...